부산대학교 도서관

Monocytes and monocyte-derived macrophages (MDMs) from blood circulation infiltrate glioblastoma (GBM) and promote growth. Here, we show that PDGFS-driven GBM cells induce the expression of the potent proinflammatory cytokine IL- 1[beta] in MDM, which engages IL-1R1 in tumor cells, activates the NF-[kappa]B pathway, and subsequently leads to induction of monocyte chemoattractant proteins (MCPs). Thus, a feedforward paracrine circuit of IL-1[beta]/IL-1R1 between tumors and MDM creates an interdependence driving PDGFS-driven GBM progression. Genetic loss or locally antagonizing IL-1[beta]/IL-1R1 leads to reduced MDM infiltration, diminished tumor growth, and reduced exhausted [CD8.sup.+] T cells and thereby extends the survival of tumor-bearing mice. In contrast to IL-1[beta], IL-1[alpha] exhibits antitumor effects. Genetic deletion of ll1a/b is associated with decreased recruitment of lymphoid cells and loss-of-interferon signaling in various immune populations and subsets of malignant cells and is associated with decreased survival time of PDGFS-driven tumor-bearing mice. In contrast to PDGFB-driven GBM, Nf1-silenced tumors have a constitutively active NF-[kappa]B pathway, which drives the expression of MCPs to recruit monocytes into tumors. These results indicate local antagonism of IL-1[beta] could be considered as an effective therapy specifically for proneural GBM.
Introduction Glioblastoma (GBM) is the most prevalent and aggressive primary brain tumor in children and adults and has poor overall survival rates. Numerous therapies have entered clinical trials, with only [...]